X
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
1. Alevaire
2. Enuclene
3. Formaldehyde, Polymer With Oxirane And 4-(1,1,3,3-tetramethylbutyl)phenol
4. Oxyethylated Tertiary Octylphenol Formaldehyde Polymer
5. P-isooctylpolyoxyethylenephenol Formaldehyde Polymer
6. Polyhydroxyethyl-tert-octylphenolformaldehyde
7. Superinone
8. Supervent
9. Translight
10. Triton A 20
11. Triton Wr 1339
12. Triton Wr-1339
13. Tyloxapol
14. Tyroxapol
15. Wr-1339
1. Tyloxapol
2. 25301-02-4
3. Tyloxypal
4. Triton Wr-1339
5. Superinone
6. Alevaire
7. Nsc90255
8. Formaldehyde;oxirane;4-(2,4,4-trimethylpentan-2-yl)phenol
9. Triton A-20
10. Formaldehyde, Polymer With Oxirane And4-(1,1,3,3-tetramethylbutyl)phenolother Ca Index Names:oxirane, Polymer With Formaldehyde And4-(1,1,3,3-tetramethylbutyl)phenolphenol, 4-(1,1,3,3-tetramethylbutyl)-, Polymer With Formaldehyde Andoxirane
11. Superiuone
12. Component Of Alevaire
13. Formaldehyde; Oxirane; 4-(1,1,3,3-tetramethylbutyl)phenol
14. Schembl181284
15. Dtxsid30179950
16. Chebi:141517
17. Nsc-90255
18. Akos026749862
19. Formaldehyde,1,3,3-tetra Methylbutyl)phenol
20. Ab01563398_01
21. Q7860340
22. Ethoxylated P-tert-octylphenol Formaldehyde Polymer
23. Wln: /qr Dx1&1&1x1&1&1/ &/*o2*/ &/*o1*/
24. Phenol,1,3,3-tetramethylbutyl)-, Polymer With Ethylene Oxide And Formaldehyde
| Molecular Weight | 280.4 g/mol |
|---|---|
| Molecular Formula | C17H28O3 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 3 |
| Exact Mass | 280.20384475 g/mol |
| Monoisotopic Mass | 280.20384475 g/mol |
| Topological Polar Surface Area | 49.8 Ų |
| Heavy Atom Count | 20 |
| Formal Charge | 0 |
| Complexity | 204 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
Tyloxapol is an inhaled surfactant that assists in removing and liquefying and removing bronchopulmonary secretions with mucus and pus. Tyloxapol is administered either through nebulized solution or a stream of oxygen. Also investigated for use/treatment in cystic fibrosis and pediatric indications.
It is used as a surfactant to aid liquefaction and removal of mucopurulent (containing mucus and pus) bronchopulmonary secretions. Tyloxapol also blocks plasma lipolytic activity, and thus the breakdown of triglyceride-rich lipoproteins.
Surface-Active Agents
Agents that modify interfacial tension of water; usually substances that have one lipophilic and one hydrophilic group in the molecule; includes soaps, detergents, emulsifiers, dispersing and wetting agents, and several groups of antiseptics. (See all compounds classified as Surface-Active Agents.)
Detergents
Purifying or cleansing agents, usually salts of long-chain aliphatic bases or acids, that exert cleansing (oil-dissolving) and antimicrobial effects through a surface action that depends on possessing both hydrophilic and hydrophobic properties. (See all compounds classified as Detergents.)
R - Respiratory system
R05 - Cough and cold preparations
R05C - Expectorants, excl. combinations with cough suppressants
R05CA - Expectorants
R05CA01 - Tyloxapol
Tyloxapol, when injected IP, blocks plasma lipolytic activity, and thus the breakdown of triglyceride-rich lipoproteins. It has also been shown to be inhibitor of lipoprotein lipase, thus preventing triglyceride uptake.
Market Place
